GlassScriptPhysician profile
John G Anderson
NPI 1700874294
$1,277,957.19
in general payments reported to CMS, 2019-2025
21 companies · $103K in 2025
The $103K reported for 2025 was more than what 95% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184K · 2020: $95K · 2021: $154K · 2022: $334K · 2023: $207K · 2024: $201K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $406K · Consulting Fee: $86K · Travel and Lodging: $14K · Food and Beverage: $4,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $406,489.83 |
| Consulting Fee | $86,368.75 |
| Travel and Lodging | $13,642.42 |
| Food and Beverage | $4,287.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $530,774.09 | 2019-2025 | Anchorage, Variax, Augment Injectable |
| Medartis INC. | $395,938.71 | 2021-2025 | Aptus |
| Paragon 28, INC. | $147,112.83 | 2019-2025 | Portfolio, Apex 3d, Additive Orthopedics |
| Nextremity Solutions INC. | $97,957.22 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $67,017.54 | 2019-2025 | A.L.P.S., Calcaneal Cuboid Disk, Nextremity General Instrument |
| Depuy Synthes Sales INC. | $14,593.78 | 2019-2025 | Motoband, Fibulink |
| Extremity Medical | $9,965.52 | 2025 | |
| Wright Medical Technology, INC. | $6,485.89 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $2,073.10 | 2021 | |
| Medwest Associates | $2,020.80 | 2020-2021 | |
| Arthrex, INC. | $1,905.12 | 2020 | |
| Gentleman Orthopedic Solutions | $1,200.00 | 2021 | |
| Synthes Gmbh | $250.00 | 2021 | |
| Acumed LLC | $201.67 | 2019-2021 | |
| Ossio INC | $120.52 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $114.64 | 2019 | |
| Heron Therapeutics, INC. | $105.71 | 2023-2024 | Aponvie, Zynrelef |
| Smith+Nephew, INC. | $57.69 | 2019-2024 | Q-Fix |
| Abbott Laboratories | $33.30 | 2024 | Proclaim |
| Olympus America INC. | $16.98 | 2023 | Olympus |
| Orthofix Medical, INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.